Humanigen, Inc. Common Stock

YTD

ALL

Why Robinhood?

You can watch HGEN and buy or sell other stocks, ETFs, and their options commission-free!

About HGEN

Humanigen, Inc. is a clinical-stage biopharmaceutical company. engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F.

CEO

Cameron Durrant, MD, MBA

CEOCameron Durrant, MD, MBA

Employees

—

Employees—

Headquarters

Burlingame, California

HeadquartersBurlingame, California

Founded

2000

Founded2000

Employees

—

Employees—

HGEN Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0067

52 Week high$0.0067

52 Week low

—

52 Week low—

Stock Snapshot

Humanigen, Inc. Common Stock(HGEN) stock is priced at $9.05.

During the trading day, Humanigen, Inc. Common Stock(HGEN) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Humanigen, Inc. Common Stock(HGEN) stock has reached 0.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.